JB Pharma News and Activities

Presence

JB Pharma develops, makes, and sells pharmaceutical products. Its main offerings include prescription medicines, over the counter products, and contract manufacturing services for patients, doctors, hospitals, and healthcare partners.

JB Pharma products and services overview:

Prescription medicines
Over the counter
Heart care
Digestive care
Pain management
Respiratory care
Contract manufacturing

Revenue: ~$420 million

Employees: 5,800

Headquarters: Mumbai, India

JB Pharma is owned by Johnson & Johnson.

Johnson & Johnson is one of the...

Johnson & Johnson is a company listed under the stock ticker JNJ (US).

Johnson & Johnson has a direct presence in 23 countries.

Johnson & Johnson has 56 subsidiaries including Abiomed, DePuy Synthes and Ethicon.

They are in:

Acquisition, funding and merger involving Johnson & Johnson.

Johnson & Johnson has announced the acquisition of Intra-Cellular Therapies (posted on January 13 2025).
Johnson & Johnson has acquired V-Wave (posted on October 9 2024).
Johnson & Johnson has announced the acquisition of Proteologix (posted on June 21 2024).

Executives

View the org chart displaying its 25 main executives

Most searched biographies at JB Pharma

Popular executive movements at Johnson & Johnson

Ryan Koors will join the company as Vice President, Investor Relations on May 6, 2026 (posted on April 30 2026).
Lauren Johnson, who was Senior Director, Investor Relations, is promoted to Chief Financial Officer, External Innovation Finance (posted on February 26 2026).
Geetanjali Gamel, who was Head of Human Resources, Global Commercial Strategy and Business Development, is promoted to Head of Human Resources, US Surgery (posted on January 5 2026).

Click here to view some more movements at Johnson & Johnson

Create your alert
to follow the executive moves at JB Pharma.